Pharmafile Logo
Pharmafocus logo
Advanced Search

Manufacturing and Production

Showing 15 posts of 5813 posts found.

Lonza looking elsewhere after retreating from Patheon bid?

October 21, 2009 Manufacturing and Production Lonza

 Lonza said it has elected not to proceed with a $460 million bid to buy Canadian contract manufacturing and development …
News

Pharma manufacturing news in brief

October 19, 2009 Manufacturing and Production Neopharma

A round-up of developments in the pharmaceutical manufacturing sector, with facility updates from Neopharma, Nextpharma and Arch Pharmalab and new …
News

Lilly finds buyer for threatened manufacturing unit

October 16, 2009 Manufacturing and Production Evonik, lilly

 Lilly has found a buyer for its manufacturing facility Tippecanoe Laboratories in Indiana, USA, which had been under threat of …
News

Green light at Angelini plant resurrects antidepressant prospects

October 13, 2009 Manufacturing and Production Angelini

Canadian drugmaker Labopharm has been boosted by the news that manufacturing problems holding up approval of its novel antidepressant product, …
News

Montreal gets manufacturing boost from Schering-Plough

October 9, 2009 Manufacturing and Production Canada, Merck

 Schering-Plough says it is planning to invest more than C$30 million ($28 million) to expand a pharmaceutical manufacturing facility in …
News

Reshuffle at Rexam creates healthcare unit

October 7, 2009 Manufacturing and Production Rexam, packaging

Packaging giant Rexam is merging three of its units into one global healthcare division headed by former Rexam Pharma chief …
News

FDA streamlines GMP for combination products

October 2, 2009 Manufacturing and Production FDA, US, reg

The US Food and Drug Administration has said it will draw up new rules on Good Manufacturing Practices (GMP) for …
News

Expansion plan at Almac prompts recruitment drive

September 29, 2009 Manufacturing and Production Almac

Northern Ireland's Almac Group has announced another raft of expansions in its contract research and manufacturing operations, which could boost …
News

Chop and change for pharma production facilities

September 28, 2009 Manufacturing and Production AZ, Teva

 
News

Nycomed earmarks $96m for Russian manufacturing

September 24, 2009 Manufacturing and Production Daxas, Nycomed, Russia

Swiss drugmaker Nycomed has provided more details of its plan to build a large-scale production facility in Russia.In July, Nycomed …
News

Gerresheimer invests further in plastic packaging

September 23, 2009 Manufacturing and Production packaging

Gerresheimer has continued its expansion into the pharmaceutical plastic packaging sector with the construction of two new plants, one in …
News

Novasep certified for high-potency API production

September 21, 2009 Manufacturing and Production Novasep

News

FDA warns Bayer over German API facility

September 17, 2009 Manufacturing and Production Bayer, FDA, reg

The US regulator has sent a warning letter to Bayer indicating it found "significant deviations from US current good manufacturing …
News

Puerto Rican ops hold back Patheon

September 16, 2009 Manufacturing and Production Patheon

 Canadian contract manufacturer Patheon has reported ‘disappointing’ third-quarter results, with a resurgence of problems at its Puerto Rican operations contributing …
News

Solvay clears hurdle in cell-based flu vaccine supply

September 15, 2009 Manufacturing and Production Solvay

A manufacturing facility in the Netherlands operated by Solvay Biologicals has passed an inspection by Dutch authorities and is ready …
News

Latest content

Eisai and Biogen’s Leqembi launched for Alzheimer’s treatment in China

June 28, 2024

AbbVie’s Tepkinly gains positive CHMP opinion for follicular lymphoma treatment

June 28, 2024

IDEAYA Biosciences announces first-patient-in for phase 1 clinical trial evaluating IDE397 and Trodelvy combination in MTAP-deletion bladder cancer

June 27, 2024

Immunotherapy created at Roswell Park Comprehensive Cancer Center given expanded ODD by FDA

June 27, 2024

Abcuro completes enrolment for phase 2/3 IBM treatment trial

June 26, 2024